pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,258 catalysts · 5,256 phase readout · 2,333 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 62 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: phase readout×type: approval×clear all
type
  • phase readout5,256
  • 8k filing2,333
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT05610059: Improving Hypertension Medication Adherence for Older Adults

Sponsor: University of Arizona. Phase: NA. Conditions: Aging, Medication Adherence, Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07580859: Antenatal vs Postnatal Transport Team Positioning in Extremely Preterm Outborn Infants

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Prematurity Complications, Neurodevelopment Outcome, Prematurity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07716059: Legume Flour Particle Size and Metabolic Responses to Bread

Sponsor: Harokopio University. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›TERMINATEDphase readoutNCT05044780: Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: COVID-19

full page →ctgov ↗
›RECRUITINGphase readoutNCT05568680: SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Sponsor: Verismo Therapeutics. Phase: PHASE1. Conditions: Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07479680: Effect of Direct Chin-tuck Against Resistance on Swallowing Function

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Dysphagia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07661680: Perianchor Cyst Formation, Tendon Healing, and Clinical Outcomes Following Arthroscopic Rotator Cuff Repair

Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Rotator Cuff Tears, Tendon Thickening, Tendon Injuries, Muscle Weakness

full page →ctgov ↗
›RECRUITINGphase readoutNCT06297980: Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Type 1 Diabetes, Hypoglycemia, Hyperglycaemia Due to Type 1 Diabetes Mellitus, Menstruation Disturbances

full page →ctgov ↗
›COMPLETEDphase readoutNCT05646680: A Performance Study of (Opportunistic) Salpingectomy

Sponsor: University Hospital, Ghent. Phase: NA. Conditions: Adnexal Lesion, Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357779: Clinical Efficacy and Health Economic Evaluation of an Intelligent Diagnostic and Treatment Model

Sponsor: Zan Wang. Phase: NA. Conditions: Insomnia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07521579: A School-based to Prevent Obesity Among Children Aged 4-7 Years- A Feasibility Quasi-Experimental Trial in Karachi, Pakistan

Sponsor: Dow University of Health Sciences. Phase: NA. Conditions: Childhood Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06660979: Using Reinforcement Learning to Personalize Electronic Health Record Tools to Facilitate Deprescribing

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Aging

full page →ctgov ↗
›COMPLETEDphase readoutNCT07472179: Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS

Sponsor: Mst.Sumyara Khatun. Phase: NA. Conditions: PCOS(Insulin Resistant)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07322679: Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults

Sponsor: Nanjing Nutrabuilding Bio-tech Co., Ltd.. Phase: NA. Conditions: Health Adult Subjects

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06633562: A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

Sponsor: Lohocla Research Corporation. Phase: PHASE1. Conditions: Healthy, Safety Evaluation of Escalating Doses, Tolerability

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06447662: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Sponsor: Pfizer. Phase: PHASE1. Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07698262: Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death

Sponsor: University of British Columbia. Phase: . Conditions: Organ Donation After Circulatory Death

full page →ctgov ↗
›RECRUITINGphase readoutNCT06517862: Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Sponsor: Amira Adel Fouly. Phase: PHASE4. Conditions: Neonatal Hyperbilirubinemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06107062: Longitudinal Outpatient Treatment for Cannabis Use Disorder

Sponsor: University of Colorado, Boulder. Phase: PHASE2. Conditions: Cannabis Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07342946: The Effects of the Mediterranean Diet and Synbiotics in Polycystic Ovary Syndrome

Sponsor: Atlas University. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04741646: Ferric Citrate and Chronic Kidney Disease in Children

Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Chronic Kidney Diseases

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04310046: Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial

Sponsor: University of Zurich. Phase: NA. Conditions: Aortic Stenosis, Coronary Artery Disease, TAVI, PCI

full page →ctgov ↗
›COMPLETEDphase readoutNCT07589946: Integrated Medical, Surgical and Physiotherapy Care for Pregnant Women With Chronic Diseases

Sponsor: Sinai University. Phase: NA. Conditions: Pregnancy, Pregnancy-Related Pain, Musculoskeletal Disorders, Physical Therapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT04868188: Pharmacokinetics of Voriconazole in Adult ECMO Patients

Sponsor: University Hospitals, Leicester. Phase: . Conditions: Aspergillosis, Influenza, Covid19

full page →ctgov ↗
›RECRUITINGphase readoutNCT06972303: Mindfulness Meditation for Insomnia

Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Sleep Initiation and Maintenance Disorders, Insomnia, Insomnia Chronic, Mindfulness, Telemedicine

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06763003: Intensive Music Therapy on Cognitive Function in Subacute Stroke Rehabilitation in Malaysia

Sponsor: University of Malaya. Phase: NA. Conditions: Rehabilitation, Cognition, Stroke, Attention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07123103: A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Sponsor: Exelixis. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT04447027: Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma, Relapsed/ Refractory T-cell Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT05418088: Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Sponsor: Sumithira Vasu. Phase: PHASE1. Conditions: Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent High Grade B-Cell Lymphoma, Recurrent Indolent Non-Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory B-Cell Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory High Grade B-Cell Lymphoma, Refractory Indolent Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Transformed Chronic Lymphocytic Leukemia, Refactory Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Non-Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07516288: Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE1. Conditions: Dilated Cardiomyopathy (DCM), Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT05351788: SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03794388: Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Sponsor: Institut Cancerologie de l'Ouest. Phase: PHASE3. Conditions: Breast Cancer Patient

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890403: Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Vaccination

full page →ctgov ↗
›COMPLETEDphase readoutNCT04570761: Effects of Auditory Brain Stimulation by "Pink Noise" on Memory Capacities in Alzheimer's Disease: Proof of Concept Study

Sponsor: University Hospital, Tours. Phase: NA. Conditions: Alzheimer's Disease (AD)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04043442: rTMS Target Identification for Functional Disability in AUD+mTBI

Sponsor: VA Office of Research and Development. Phase: PHASE2. Conditions: Alcohol Use Disorder, Mild Traumatic Brain Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07276542: Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

Sponsor: The Ketamine Research Foundation. Phase: PHASE2. Conditions: Phantom Limb Syndrome With Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07511608: Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Mitochondrial Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07661108: A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06358508: Sapphire 3 CTO Study

Sponsor: OrbusNeich. Phase: NA. Conditions: Coronary Artery Disease, Coronary Disease, Myocardial Ischemia, Heart Diseases, Arteriosclerosis, Cardiovascular Diseases, Chronic Total Occlusion, Chronic Total Occlusion of Coronary Artery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07353008: Effect of Different Chelation Protocols on the Healing of Periapical Lesions in Teeth With Chronic Apical Periodontitis

Sponsor: Mustafa Kemal University. Phase: NA. Conditions: Chronic Apical Periodontitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05301608: Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought

Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07598825: A Trial of Inebilizumab in Participants With Autoimmune Hepatitis

Sponsor: Amgen. Phase: PHASE3. Conditions: Autoimmune Hepatitis, AIH

full page →ctgov ↗
›RECRUITINGphase readoutNCT07345325: Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Sponsor: Nantes University Hospital. Phase: PHASE3. Conditions: Infective Endocarditis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07016308: Low-Flow Desflurane vs Sevoflurane: Impact on Physiology and Recoveryand Recovery Profiles in Adult ENT Surgery

Sponsor: Harran University. Phase: NA. Conditions: Anesthesia, General

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575308: HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

Sponsor: Alnylam Pharmaceuticals. Phase: PHASE2. Conditions: Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07432425: Effects of Different Exercise Protocols on Physical and Cognitive Changes in People With Chronic Neck Pain

Sponsor: Hacettepe University. Phase: NA. Conditions: Neck Pain, Chronic Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT06333925: Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Sponsor: Duke University. Phase: NA. Conditions: Misophonia, Emotion Dysregulation, Sensory Processing Disorder, Auditory Over Responsivity, Anxiety Disorder, Sound Sensitivity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06318325: Growth Process and Development of the Musculoskeletal System in Young Gymnasts

Sponsor: University of Haifa. Phase: . Conditions: Development, Adolescent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07589725: Mulligan Mobilization in Lateral Elbow Tendinopathy

Sponsor: Istanbul Kent University. Phase: NA. Conditions: Lateral Elbow Tendinopathy (Tennis Elbow)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04334525: Promoting Healthier Eating Among Children in Restaurants

Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Diet, Healthy

full page →ctgov ↗
← prev
page 105 of 106
next →